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The cellular origin ofleukotriene B4 (LTB4)' a potent 
pro-inflammatory molecule present in psoriatic le-
sions, has yet to be determined. In the present study, 
cultured human keratinocytes were evaluated for 
their ability to produce LTB4 • Keratinocytes stimu-
lated under a variety of conditions did not produce 
detectable amounts ofLTB4, as measured by enzyme 
immunoassay and liquid chron1.atographic tech-
niques. Prostaglandin E2 and 15-hydroxyeicosatet-
raenoic acid were the only eicosanoids detected. The 
capacity of keratinocytes to synthesize 5-lipoxygen-
ase (5-LO) products, or lack thereof, was further 
evaluated by preparing subcellular fractions and ex-
amining them for the presence of 5-LO activity and 
L cukotriene B. (LTB .. ) is a potent proinflammatory agent formed by the oxidation of arachido nic acid th rough the 5-li poxygen <lse (5-LO) pathway (reviewed in Ford-H utchin son ct n/, 1994). T he action s of LTB" include leukocyte chemotaxis and aggregation (Smith , 
1981 ; Borgeat and Neccache. 1990), and, as such, this m ediator 
plays an important role i.n a number of inflammatory diseases , 
·including psoriasis (Brian el (//, 1984) . Ruzicka cl (/ / (1986) have 
shown LTB. levels to be significantly higher in lesional psoriatic 
Skill than in uniJ1Volved skin fi'om the same subject. In addition, the 
topica l application ofLTB4 to normal skin caused an acute inflam-
matory response ch aractelized by the accumulation of ne utrophil s 
(polymorphonuclear le ukocytes [PMNsJ), microabscess formation, 
and epide rmal hyperproliferation (Camp c{ (//, 1984; Bauer cl (//, 
1986), conditions similar to those seen in psoriatic lesions. A rol e 
for LTB .. in psoriasis was furth e r suggested by a c linical stud y in 
which the topical administration of lonapo lene, a 5-LO inhibitor 
(Bhlck el (//, 1990), resulted in a sign ificant improvement of the 
treated lesions . 
A lthough LTB., appears to be a factor in the pathogenesis of 
psoriasis, its source remains to be clea rl y defined. Keratinocytes 
isolated from freshly excised normal human skin, when stimulated 
w ith the calcium ionophore A23187 in the presence of arachidonic 
ac id (AA) , we re reported to secrete a chemotactic factor whose 
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the proteins responsible for LTB4 production. Using 
Western blot analysis, we detected no bands that 
migrated with the 78-kDa 5-LO enzyme. Subcellular 
fractions were also examined for the presence of the 
5-LO-activating protein (FLAP). This protein, which 
is essential to 5-LO activity, could not be detected in 
any keratinocyte preparation examined. Consistent 
with the absence of proteins, the n1.RNAs for 5-LO 
and FLAP were undetectable by reverse transcriptase 
polyn1.erase chain reaction analysis . These results 
demonstrate that human keratinocytes lack the cru-
cial proteins necessary for LTB4 production. Key 
,voltds: a vaclridollic acid 15 -lipoxygellaselS -I ipoxygellase-acti-
vati"g p,totei". ] Invest DevlIJato/ 106: 162-167, 1996 
activity was diminished by the 5-LO inhibitor, BW 755C (Grabbe 
et (/ /,1985) . Although this factor coeluted with sta ndard LTB" when 
anal yzed by reverse-phase high-press ure liquid chromatography 
(RP-HPLC) , an ultraviolet spectrum of the ch aracteristic tricne 
structure was not presented . Similar results were obtained utilizing 
fi'eshly iso lated keratinocytes that were purified by fluorescent-
activated cell sorting (Rosenbach ct (/ /, 1990). In contrast, other 
groups have shown that fi'esh ly isolated kerarinocytes do not 
produce detectable amounts of LTB4 upon stimulatio n , but that 
they arc able to convert PMN-derived le ukotriene A~ (LTA4) to 
LTB" (Sola el (//, 1992; Iversen cl (//, 1993). 
T he present study was undertaken to examine the ability of 
human kerati.l1ocytes to produce 5-LO products. This question was 
first addressed by investigating the profi le of e icosanoids produced 
by keratinocytes under different sti mulatory conditions. Secondly, 
keratinocyte subcellular fi'actions were examined for the 5-LO 
enzyme and 5-LO activating protein (FLAP) using spec ific antibod-
ies. Finally, the mRNA levels for these proteins were analyzed by 
reverse transcriptase polym erase cha in reaction (RT- PCR) . These 
studies suggest that human keratinocytes do not possess the 5-LO 
enzyme or FLAP, and, therefore . cannot produce LTB.,. 
MATER.lALS AND METHODS 
Materials Arachidonic (5 ,8.11 ,14-cicosatctracnoic) acid was purchased 
from Nu-Chck-Prep Inc. (Elysian, MN) . r"'C]-A A (52.0 mCi/ mlllo l) was 
purchased from Amcrsham Corporation (Boston. MA) . All HPLC st'lIIdards 
were Ii'o rn Biomol (PI),mouth Meeting, PAl. 1-lulTlan recombinant interfcr-
on-")I was purchased &0111 R&D S),stems (Minneapolis, MN). Human 
recombinant int.crl eukin-1 f3 (IL-I (3) was prepared as previousl), desc ribed 
(Meyers c/ ai, 1987). 1,25-Dihydroxyvitamin 0 " was a gift from Dr. Milan 
Uskokovic, Hofl:inan-LtI'tochc Laboratories (Nutley, NJ). All so lvents were 
purchased fi'o l11 J.T. Baker, Inc. (Phillipsburg. NJ). Unless otherwise 
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indicated. all other reagents and chemicals were obtained fi'om Sigma 
Chemical Co. (St. Louis, MO). 
Cell Culture HUll1an ncol1;1ta l forcslcin keratlllocytcs \,,",ere purchased 
from Clonetics Corporation (San Diego, CAl. The)' we re grown as 
monO layers at 37"C, 5'!!" COo in keratinocyte growth m edium. a defined 
serum-free, low-calciulll (0.15 mM) m edium (Clonctics Corp ., San D iego, 
CAl . Second passage cells. (70 - 90'10, confluent) were used in all experi-
ments. 
L TB. Production front Adherent Keratinocytes Kerntinocytc cul-
wres were left untrcared o r pretreated with e ither IL-l (1 ng/ml. 4 or 48 h) , 
or interferon-), (to o r 100 U / ml. 48 h) . At the time of the ex periment. the 
culture m edia was removed and replaced with 1 ml of fi'esh keratinocyte 
growth medium containing o ne of ,he following stimulants: A23187 ('I 
jLM) , phorbol m Ylistate acetate (PMA) (1 jLM). or bradykinjn (I jLM). The 
plates were then incubated at 37°C for 20 min. At the end of the incubation, 
the supernatants were co llected and assayed for LTU., by c llzymc immuno-
assay (Caylllan C hel1li ca l Co., AIIIl Arbor, MI). 
LTB. Production from Keratinocytes in Suspension Kcratinocytc 
cultures were left untreated or pretreated with o ne of the following agents: 
1L-1 (1 ng/ml. 1 d) . dexamethasone (10 nM , 5 d). or 1,25-dihydroxyvita-
min D3 (10 nM , 5 d). The keratinocytes were then harvested by trypsiniza-
tion and resuspended in Dulbecco's phosphate-buffered sa line to a concen-
tration of2 X 10" ce lls/1Il1. O lle-milliliter "Iiquots were scimulatcd with the 
foUowi ng agents for 10 min at 37°C: calcium ionophorc A23187 (2 or 5 
jLM), PMA (1 /-tM), o r A23187 (2 J.LM) plus PMA (1 jLM). Thereafter. the 
kcratinocytes w lere placed o n icc, centrifuged at 2500g for 15 min . 4°C, and 
the supernatants co llected and analyzed for LTB" as described above. 
Arachidonic Acid Supplementation In order to rule o ut a lack of 
substrate, arachidonic acid sllpplem entation was investigated. In the first 
series of studies. kcratinocytes in sll sp ensio n were pre incubated with 
dexamethasone or 1,25-dihydroxyvitamin D ;\ and then stimulated with 
A23 187 (2 I1.M) in the presence o f AA (50 J.LM) as described above . 
Al te rnatively. kc ratinocytcs in slIspensio n 'were stinllzlatcd ,vi th ar;lchidonic 
acid (50 J.LM, 100 jLM) only. 
10 other studies, the medium of adherent keratinocytes was supplem ented 
wi th AA (1 jLM final concentration added in a bovin e serul11 albumin 
solution) for 24 h prior to stimulation with A23 187 (2 jLM) , PMA (1 jLM), 
or a combinatio n of the two as described above. The enrichment of the 
ceLlu lar arachidonate content waS verified by gas dlromatographic an alysis 
of the membrane phospholipid fatty acids as their filtty acid methyl ester 
derivaties (R.ogozinski, 1964). 
HPLC Analysis of Eicosanoid Metabolites Sarnples were prepared for 
HPLC as follo"v s. K\!ratinocytes were harvested by t rypsinization and 
resuspended in Dulbecco' s phosphate-buffe red saline w ith c<l \Cium and 
magnesium at a concen tration of '1. 2 X 107 keracillocytes/ ml. Each sample 
(0. 5 ml) was prewarmcd ;It 37°C for 5 min and th!!n stimulated with A23187 
(2 flM) in the presence of2 /-LCi ["'q-AA for 60 min at 3rc. Prostaglandin 
£ 2 (200 pmoles. illternaJ standard) was then added after w hich the reactions 
were stopped by the addition of 5 ,.u of 1 N HCI , followed by four vo lumes 
of ice-cold ethyl acetatl!. The o rganic layers were collected and dried lInder 
a stream of argon. T he residues were resuspended in ZOO jLl 50% methano l 
for analysis by l-IJ'LC. 
T he samples were loaded o nto a R C M NOVA-PAK C'H 100 X 5 mill 
columll (Waters Associates. Mjlford. MA) and eluted with a starting mobile 
phase of 84'11" A (A = 15'X, acctonitri.le/O .l 'Yo acetic acid /84.9% wate r) and 
16% D (D = 99.9%, acetoni tril e/O.l % aceti c :lcid) . T he Row ratc was J, 7 
m i/ nljn. After 10 tllin. the 'X,13 was inc reased to 21 IX, ove r 2 111in the n 
allowed to run isocratically for 13 min. Over the next 2 min , the "A,B was 
linearly increased 44%, and then increased to 51% over lU mju . Finally , the 
%B was increased ill a CO li vex function to 100% over 2 min , then allowed 
to run isocraticall y for 5 min. T he retention times (min) fo r the standards 
were: thromboxalle Bo, 3.1; prostaglandin Eo, 5.1; prostaglalldin D 2 • 5.9; 
prostaglandin 0 " 13.8; L T B .. , 21.2; 15-hydroxyeicosatetracnoic acid (15-
HETE) , 30.4; 12-HETE, 31.2; 5-I-fETE, 3 1.8; and AA, 43.3. The colu111n 
effluent was mo nitored for radioactivity alld spectrophotolllettica ll y {j'0111 
190 to 310 nm. T he products in the sample were identiftcd by comparison 
oE their rete ntio n times to those of known standards and by their ultra vio let 
absorbance spectra. 
Assay of 5-LO Activity Keratinocyte 5-LO acttv lty was assessed by 
monitoring the consumption of o""Ygcn, essen tially as described by Dre ton 
£I al (1993). Ke ratillocytes were harvested by trypsinization , washed , and 
resuspcnded in 50 mM sodium phosphate buffer (pH 7 .0) containing 1 111M 
cthylenediamine tetraacetic acid , to a concentratio n of 5 X 107 cclls/ml. 
The cell s were disrupted b), nitrogen caviwtio n (450 psi, 15 lIlin) using a 
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Parr bomb placed i11 an ice bath. T he hOlllogena te was centlifuged (lOOOg, 
4°C, 10 min) and the supernatant collected. Ethylene glyco l (Pierce 
C hemical Co .. Rockford, IL) was added to " ~illa l concentratio n of 5% and 
the mixture was centt'ifuged at 100,000g for l h at 4°C a lld the cytosol 
collected. 
T he kcratinocyte cytoso l (167 /-tg protein) was prcincuhll ted in 25 mM 
Bis-Tris butte r (pH 7.0) con ta ining 1 mM c til )' lened ial1lille tecraacetic acid , 
2 111M ATP. and 150 mM NaCI for 3 min at 20°C (total vo lu llle 1 .9 7 ml). 
T he reaction was started with the addition of arachidon.ic acid ( 10 /J.M) and 
CaCl, (2 mM, final volume 2m l), and the consumption of oxygen was 
1I1 0lli towd lIsing a C lark-type electrode with a Yello w Springs m odel 53 
o""Ygcn monitor (Yellow SpJ';ngs, O H) and all onsct amplifier (Sig ma 
Electronics, King of Pruss ia, PAl . W hen th e reactio n plate'llI cd, it was 
stopped by the addition of an equal vo lumc of ice-cold acetone con tain.ing 
200 pmoles of the i.lltcrnal standard prostaglandin Do. vortcxed, and kept On 
icc for 15 min . T h e sample was extracced w ith fou.r volumes of icc-cold 
ethyl acetate. T he organic laye r was collected. dried under argon. and 
resuspended in 200 /J.I 50% methano l for analysis by HPLC as described 
above. 
Preparation of the 5-LO and FLAP Antibodies A female New 
Zealand W hi te rabbit was immunized with 150 jLg of recombinant human 
5-LO emulsified with an equal vol ume ofFre lJlld' s com pi etc ,,<\jnvant . After 
3 wks, the rabbit was boosted with 200 /-Lg of recombinant 5-LO in Freund 's 
complete adjuvant. Bleeding was performed 5 wk afte r the primary 
immunization. Dilu ted sera was used in the \ Xlestern blots. T he FLAP 
antibody, a rabbit anti-human polyc1onal antibody (Miller ct nl, 1990), was 
a gjft from Dr. Jilly Evans of the MeJ'ck Frosst Centre fo r T herapeutic 
Research (Pointe C laire-Dorval, Quebec, Canada). 
Subcellular Fractionation o fKeratinocytes Kcrarinocytes were har-
vested and resuspe nded to a concentratio n of 5 X 107 cells/ml in hornog-
eniza tioll buffer (0.3 M sucrose, 10 111M N-2-hydroxyethylpiperaz ine-N '-
2-ethanesul foni c acid [pH 7.4J, 1 mM ethylene glycol-bis-[,B-amin oeth yl 
ether]- N .N ,N' ,N ' tctraacetic acid , 1 111M phenylmethylsulfonyl fluo ride. 
200 jLM leupeptin . 20 J.Lg / IllI soybean tryps in inhi bitor. and 20 jLg/ ml 
ap rotin.in) . T he kc rati nocytes were d isrup t.ed by nitrogen cavitat.ion (450 
psi, 15 luin, 4°C ) using a Parr bomb, celltrifuged at 1000,!,' for 15 min at 4°C 
and the resul ting supernatant centrifuged at 100 ,000S lor 1 h at 4°C. The 
cytoso li c fi'a ction was decanted and the microsomal fi'action was resus-
pended in homogenization buffer in a volume equal to the cytoso lic 
lTactioll. Both fi'actions were /i'o;,el1 ill liquid nitrogen and stored at - SO°C. 
Cytosoli c and microsomal prepanltions fi'ol11 fi'\!shl y iso lated human 
PMNs (Boyum. 1968) were prepared as described above to Serve as positive 
controls in the im!11unoblot. 
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis and 
Western Analysis Kcratinocyte (30 /-tg protein) and PMN (10 /-tg 
protein) fractions were separated by sodium dodecyl sul f.1te-polyacrylall1 ide 
ge l electrophoresis (Laemmli , 1970) and tra nsferred to lIitrocellu.lose paper 
(J1ybolld-EC L; Al1lersham Corp ., Arlington H eights. IL). T he nitrocellu-
lose sheets IVcre blocked , incubated witb th e primary amibody, washed. and 
then incubated w-ith \t orscr"d ish peroxjdase-Inbcled anci-J<abbit antibody 
(Amersham) . ImllJunoreactive bands were detec ted using the Enhanced 
C hemiluminescence Weste rn blotting system (Al1Iersham). 
RT-PCRAssay Tota l RNA was prepared fi'o l1l kenltinocytes by the acid 
guanidiniulll thiocyanate/ phenol!chlorotorm extraction procedure (Chol11-
czynski and Sacchi , 1987). RNA was also purified (rom PMNs. which were 
isolated as described above; ;lIId monocytes. which were isolated using the 
m ethod of Colatta 1'( nl (1984). All of the R.NA samples were treated with 
DNase (Deoxyribo nuclease \, ampli fication grade; Life Techno logies. Inc .. 
Grand Island, NY) before usc. T he conve rsion to cDNA and DNA 
amplification was can-ied o ut usillg the GeneAmp RNA peR kit (Pe rkin 
Elmer, ]3rallchbury , NJ). T he primer sequences (forward and backward) for 
5-LO arc: 5' -TCTACAACGACTTCGAGCGTGG-3'; and 5 '-GCAGC-
CATTCAGGAACTGGTAG-3'. The primer sequellces (forward and back-
ward) for FLA P arc: 5'-CCATAAAGTGGAGCACGAAAGCAG-3' ; and 
5'-GGA ATGAGAAGTAGAGGGGAGATGG-3'. D upLica te sa mples were 
run thro ugh the e ntire assay \~' i th no reve rse transcr iptasc . As positive 
controls tor amplification, fu ll-length eDNAs for 5-LO and FLAP (1 ng) 
were included in the PCR portion of t1w "" ay . The kit-included contro l 
was also run ill each assay, w hich amplifies a 308-bp sequence from the 
pA Wl 09 plasmid. Aliquots (15 jLl) of the PCR. samples were clectt'opho-
rescd in 1. 5%1 agarosc gels in T ris boratc/cth ylcll cd i;lIninc (crraacca c acid 
bufl:cr. T he bands were \risuali zed by ethidiulll bro mide sta.i lling . 
Protein Determinations and Cell Viability Protein concenrrario n 
were determined according to the method of Urad ford (1976). Cell viabllity 
for suspended ce ll s lVas determined by rrypilll blue cx IIISiol1 . Adhere nt cell 
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viability was assessed by utiljzjng the NelltraJRed il ioassay (Ciol1ctics 
Corporation, San Diego. CA). 
RESULTS 
Cultured Keratinocytes Do Not Produce LTB4 In order to 
assess the ability of kcratinocytes to produce LTB", adheren t ce lls 
were stimulated w ith A23187, PMA, or brlldykinin . T hese stimujj 
were unabl e to induce production ofLTB4, as mcasured by enzym e 
immunoassay (limit of detection 7.8 pg/ml). In addition, keracino-
cytes prcrrc<,ted with 1L-1 or interfcron- y, agents which ha ve been 
shown co upregulate 5-LO in other system s (Borish eI fl l , 1990; 
Kawada el fl l , 1990), did not produce LTB • . 
In order to increase any possibl e signal , keratinocytes were 
harvested and resuspended at a con centration of 2 X 10(' cells/ml. 
T he cell suspensio ns were stimulated with A23 187, PMA, or a 
combinati on of the two. However, no LTB., co uld be detected 
und"r these conditio ns. Furtherm ore, if the cell s were pretreated 
with eith er IL-1, 1,25-dih ydrm,),vitamin D 3 , w hi ch has also been 
shown to upregulate 5- LO (Coffey el fll, 1993) , or dexamethasone, 
LTB1, production was no t observed after stimulation. Cell viabi lity 
was not affected by any of the pretreatments. 
In order to confirm the find ings o n LTB., production obtail1ed 
using the enzyme immunoassay, keratinocyte suspensions were 
stimulated with 2 ,u.M A23187 in the p resence of 2 ,u.M [\4C]-AA, 
and the supe rn ata nts an alyzed fo r eicosanoid me tabolites by RP-
HPLC (Fig 1). Upon comparison with known standards (Fig 
lA,D), two major peaks were revealed . Peak [ corresponded to 
prostaglandin E2 , w ith no other products of the cyclooxygenase 
pathway being present (Fig 1B). Peak IJ corresponded to 15-
HETE, which was detected rad iochemicall y (Fig 1E) as well as 
spectrophotometrica lly (Fig 1F). A scanning spectrogn'ph of peak 
11 confirm ed its identity, showing a peak abso rban ce at 236 nm 
(data not shown). A tlurd peak (Fig lE,F) migra ted closely to the 
12-HETE standard . However, a scalming spectrograph showed its 
maximum absorbance to be 261 11m, thus negating the possibility of 
its being a monohe te. Radi oactive LTB" could not be detected in 
thi s expel'im ent, nor was it detected spectrophotometric,lll y (Fig 
lB,C). T he detection limi t for LTB4 standard was 2 .5 pl11oles. 
Another 5-LO product, 5- HETE (Fig lE,F), was also undetect-
ab le . 
To assess further the lack of LTB.\ production, a keratil10cyte 
cytosolic fract ion was prepared to directly assess 5-LO activity. 
First, lipoxygen <Jse activity in the cytosol was monitored by mea-
suring the consu mption of ox)'gcn in th e presence of ar;lchidoni c 
acid and ca lcium. No me,]surable oxygen consumption was seen 
(data not shown). T he sam e sa mples were then analyzed by 
RP-HPLC. Aga in , no products of the 5-LO enzyme could be 
detected (data not shown). 
Lack of 5-LO Products Is Not Due t o a Lack of Substrate 
Previous studies have indicated that keratin ocytes grown in serul11-
free medium becom e esse ntial ultty acid deficient after one passage 
i\l culture (Marcelo el fl l , 1990). T herefore, the possibili ty existed 
that the hick of LTD" synthes is was d ll e to the absence of the 
endogeno Ll s substrate AA. Keratinocytes in suspension fai led to 
produ ce LTB" upon stimulation when AA was provided as an 
exogenous substrate at the time of stimulat ion, suggesting that a 
lack of substrate did not underlie th e inabijjty to produce LTB 4 • 
T he above finding was furth er supported by additional expel;-
ments in w hich keratinocyte cultures were supplemented w ith 
ara chidonic acid for 24 h prior co stim ulation. Such a supplem en-
tation protocol resu lted in an approximate 2-fold increase in the 
endogeno us phospho lipid arachidonate con ten t (1 .32 iJ-g/culture 
prior to supplementa tion I;am.\' 2.34 iJ-glcu lture after 24 h suppl e-
m entation w ith 1 /.kM AA). Despite the dram:lti c increase in 
arachidonic acid content, no increase in L TB" production was 
observed upo n stimulation. T hus, the inability of keratinocytes to 
produce 5-LO products weTC probably not likely due to a lack o f 
substrate . 
T H E JOURNAL OF IN VESTIGATIVE DERMATOLOGY 
Keratinocyte Subcellular Fractions Lack 5-LO and FLAP 
To investigate further the lack of LTB.\ production by keratino-
cytes , subcellular fract io ns were prepared to ex amine them for the 
5-LO and FLAP prote ins by westem blot analysis. N either the 
microsomal nor cytosolic fi'actions were iml11un opositive fo r 5-LO 
(Fig 2) . As a positive control, PMN cytosol displayed an iJllIll LIJIO-
reactive band of approximately 78 kDa, corresponding to 5-LO 
(Fig 2). 
T he 100,000g mic rosomal fractions £i'o lll each of four keratino-
cyte preparations were analyzed by Western analysis for FLAP 
protein (Fig 3). The mi crosom al fraction fi'ol11 PMNs displayed an 
immu noreactive band at appro~ .. :imatcly 18 kDa (Fig 3, lalle 1). 
which corresponded to FLAP protein , but no band wa s detected ill 
any of th e keratin ocyte fraction s tested. 
Keratinocytes Lack mRNA for 5-LO and FLAP Northenl 
blot analysis of RNA from two keratinocyte preparations suggested 
that the mRNA for 5-LO and FLAP were absent (data not shown). 
T herefore, the more sensitive technique of RT-PCR. was em-
ployed. T he anticipated 598-bp 5-LO fi-agm ent was clearl y evident 
in the lanes con ta ining human mOl1ocyte and PMN mRNA, as well 
as in the 5-LO cDN A positive contro l (Fig 4) . Neither keratinocyte 
preparacion contained the expected size band (F igure 4). A 
redu ction of the annea ling temperature of the PCR reaction by five 
degrees yie lded identical resul ts (dat'l not shown). 
The FLAP o ligonucleotide primers produ ced a 402-bp fragm ent, 
as seen in the FLAP cDNA positive contro l (Fig 5). T he PM 
RNA also showed a fa int band of approximately 400 bp. However. 
both lanes also displayed a band of 500 bp. T he reason for this band 
is unknown but could be due to a larger splice variant of FLAP or 
primer selection. Altering the conditions of the p e R assay had no 
effect on the 500-bp band (data not shown) . T he keratinocyte RNA 
preparations showed no band corresponding to the FLAP fragment 
(Fig 5) . As a control for RNA integri ty, both keratinocyte RNA 
sampl es were ampjjfi ed usin g primers for glycera ldehyde 3-phos-
phate deh ydrogenase (Cion tech Laboratories, Palo Alto, CAl. Both 
samples produced the expected size bands (data not shown) . 
D ISCUSSION 
Literature precedent has suggested that LTB" plays a significa nt role 
ill th e etiology of psoriasis. ft is present ill e levated levels i.n psoriatic 
lesio ns (Ruzicka et fl l , 1986), the d isease can be ameliorated with a 
5-LO inhibi to r (Black el fl l, 1990), and its appli cation to normal skin 
results in acute inflammation mimicking th e disease (Camp et ai, 
1984; Bauer et aI, 1986) . Although the importance of LTB" ill 
psoriasis has been verified , the cellul ar sou rce for th is mediator is 
still a matter of conjecture. While some investigacors have reported 
that keratinocytes are ab le to synthesize 5- LO products (G rabbe er 
ai , 1985; Rosenba ch CI fl l , 1990), others have been unable to detect 
the products of this enzym atic reaction (Sol;\ e( ai , 1992; Iversen el 
ai, '1993) . T he re fore , the goa l. of the presen t undertakin g was to 
provide defi nitive evide nce for the "bi.l ity, o r lack thereof, of 
human keratlnocytes to prod uce 5-LO prod ucts. 
To this en d, cul tured hum;U1 keratinocytes were stimulated with 
various agents including A23187 and PMA, all of which fal led to 
indu ce LTB4 synthesis. IL-1, interferon-y, and 1 ,25-dihydroxyvi-
tamin D J have been reported to up regulate th e 5-LO pathway in 
other ce ll system s (Borish CI ai , 1990; Kawada CI fl l , 1990; Coffey el 
ai , 1993). In addition, we have shown that when I~BL-1 cells are 
cultured in low concentrations of dexa m ethasone, higher levels of 
5-LO protein are obtained (unpubli shed observation) . H owever, 
none of these pretreatments induced the production of L TB~ . 
These res ults were verified by HPLC, in w hich no products of the 
5-LO pathway were seen. Our resul ts are in agJ'eem ent with Sola e/ 
nl (J 992) and Iversen et fli (1993), w ho also showed that keratino-
cytes alone could not produce LTB 4 . There is no deal' explanation 
for th e discrepallcy between the data presented he rein and those of 
other authors w ho could detect 5-LO products (P...osenbach et al. 
1990) or the presence of small am o unts of LTB,,-like activity 
(Grabbe c/ ai , 1985) . Howeve r, since the in vestigators who detected 
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F ig u re 1. Keratillocyt e SoLO pro ducts a re no t detected b y RP-HPLC. Suspended hUlllan keratinocytes (6 X 107 cells) were stimulated w ith 2 /-LCi 
['4Cj-AA and 2 /-L M calcium io nopho re A23 '187 for 60 m in at 3 rc. T he reaction was terminated w ith the add ition of 5 /-LI 1 N HC\. and the produces were 
extracted w ith ethyl acetate for analys is by R P- HPLC as described in Mar,''';"Is n/"I Methods. Colul11n dil uen t was monitored at 205 IIIn (A ), 235 nl11 (D.F) . 
2 70 nm (A,C), and rad ioactively (B.E) . T he retc ntion ti mes of the products in the sample (B.C.E,F) wcre compared w ith those of know II standards (A .D). 
T he resul ts arc representative of three cXpCril1 lCll ts . 
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Figure 2. 5-LO protein is absen t in keratinocytes. Microsome and 
cytosol fractio ns (1 OO,OOO,~, "I h) of PMNs (pos itive control) and five 
kcratinocyte preparations were separated on a 7 .5'X, sodium dodccyl su lf.1te-
polyacrylam ide gci and electrophoreticall y transferred to nitrocellulose 
membranes. T he proteins were immunoblotted with anti-5-LO polyclona l 
rabb it serum. The bands were visualized as described in Nlaterials allli 
Methods. Lalles I and 2, 30 fLg microsomes fi'om two keratinocyte prepara-
tions; lalles 3, 4. and 5 , 30 fLg cytosol from three keratinocyte preparations; 
PNIN, J 0 fLg PMN cytosol. 
LTB" used ft'es hl y isola ted keratinocytes, there is the possibility of 
contamination by other cell types , includin g melanocytes, Langer-
hans cell s, fibrob lasts, o r othe r ce lls of d e rma l o rig in. 
It has been shown that keratinocytes grown in serum-lice 
m edium become essential fatty acid defic ient after o ne passage in 
culture (Marcelo el ai, 1992). Since LTB" is d e rived liOll1 AA, an 
essential fatty acid , the possibility existed tha t the inabil ity to 
produce le uokotrienes was related to a lack of substrate. Neither 
the addition of AA at the tim e of stim ul ation nor preincubation with 
AA for 24 h prior to stim ulation resul ted in the pro du ction of LTB" , 
suggesting that a lack of substrate was unlikely to underlie th e 
inability to produce LTB". T his was further suppo rted by the 
ftnd in g that stimulated keratinocytes m anuf.1.ctu red othe r e ico-
san o id produ cts, in agreement w ith earlie r studies (Pentland an d 
Ma ho ney, '1990; Burra U e/ ai, 1988). A lso, a d e fect at the level of 
arachidonate re lease is unlike ly, as w e have shown th at kerati no-
cytes possess an 85-kDa phospholipase A, w hi ch cleaves the 
. substrate AA from the phospholipid pool (M~Cord el ai, 1994) and 
that no 5-LO produ cts were formed ill the prese n ce of exogeno us 
AA. 
As pointed o u t recentl y, tbe presen ce of 5-[,0 in human 
ep iderm is remains a point of contention wh ich wi ll b e resolved only 
w hen the cells (i.e. keratin ocytes) arc examin e d for the presence of 
the proteins and mRN A involve d in the production of 5-LO 
products (Ford-Hutchinson, 1993). To t his end, human ke ratino-
cytes were fract io n ated and examine d for the presence of 5- LO and 
FLAP, prote ins necessa l'y to the prod uction of 5-LO products. 
Immunoblots of both cytosolic and microsomal preparations for 
5-LO were negative for the protein. T h ese data were further 
supporte d by the lack of mRNA for 5-LO . 
F ig ure 3. FLAP protein is ab sent in keratinocytes . Microsome &ac-
tions (1 OO,OOO.~, 1 h) were prepared fi'om five keratinocyte preparations and 
human PMNs (positive contro l). and separated on a 12% sodium dodecyl 
sulf.1te-pol yacrylamide gel. fo llowed by electrophoretic transfer to a nitro-
cellulose membrane. The proteins were immunoblotted with anti-FLAP 
polyciona l rabb it senUll , and the bands visuali zed as described in Materials 
nlld Met ilods. L(l II e> 1 through 5. 30 lJ.g microsomes &om five keratinocytc 
preparations; PMN, 10 fLg PMN microsomes. 
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F igure 4. 5-LO mRNA is absent in keratillocytes. Tota l .RNA wa 
prepared from kcratinocytes, mOllocytes, and neutrophil s, then revc rsc-
transcribed and amplified for 35 cycles as described in Mnteri" ls alld Methods. 
Samples were electrophoresed in a 1.5% agarose gel and visuaHzcd by 
ethidium bromide sta ining. Lnllt' '1, pAWl 09 plasm id (kit control); lilll es 2 
and 4, keratinocyte RNAs (0.9 fLg each) ; lall es 3 and 5, keratinocytc RN As 
minus reverse transcriptase (RT); Inlle 6, monocyte RNA (0. 1 fLg); lalle 7, 
monocyte I~A minus RT; I,,"e 8, neutrophil RNA (0.6 fLg); lalle 9, 
neutrophil I~A minus RT; Inlle 10, J IIg full- length 5-LO cDNA (peR 
only); Oil/side 1nlles, the DNA ladder. 
Activation of the 5-LO e nzyme requires its translocation to the 
nuclear membrane , w he re it binds to FLAP (Woods et al. 1993) . 
In vestigators h ave shown , using transfecte d osteosarcom a cells 
(Dixon et ai, 1990) and other cell s (R e id c/ ai, 1990), that ce llular 
le ukotrie n e synthes is is dependen t on the co-expression of 5-LO 
and FLAP, n e ither protein be ing sullicient on its own. T h erefore, 
the absence of FLAP in the five keratinocyte microsom al prepara-
tions tested accompanie d by the absence of FLAP mRNA would 
make the produc tion of LTB4 unlike ly. 
R ecently, J anssen-Timmen ei al Uan ssen-T imme n cl ai, 1995) 
d e m onstrated upregulated productio n of 5-HETE an d LTB" and 
the expression of5-LO protein and m RNA ill dillerentiated HaCaT 
cell s, a transformed human keratinocyte cell line . It was also stated 
that primary hum an keratinocytes express 5-LO mRN A, protein, 
and cell-free e nzyme activity. But those data were not presented. 
W itho ut knowing the source of primary keratinocytes, or the exacr 
expe rimental m e thods applied it is diffi c ult to comm e n t on their 
findiJlgs. 
T he present study has in vestigated the controversial question of 
LTB" production by cu ltured human kerati nocytes. Cell s stimu-
lated und er a variety of condit io ns did n ot produce detectable 
amounts of LTB". Definitive evidence for th e mechanism under-
lying th e inability to synthesize 5-LO produ cts was obtaiJl ed when 
the cell s were exa min ed for the presence of the proteins responsible 
for their produc tion . 5-LO and FLAP could not be detected , no r 
could the mRNA respo nsible for the ir production. T hu s, c ultured 
ke ra t inocytes do not possess the com po ne nts necessary for produc-
tion ofLTB" . 
Figure 5. FLAP mRNA is absent in kcratinocytes. Tota l l~A was 
prepared &om keratinocytes and neutrophil s, then reverse-transcribed and 
amplified for 35 cycles as desc ribed in Mnterin ls nlld Methods. Samples were 
dectrophoresed in a 1.5% agarosc gel and visuali zed by ethidium bromide 
staining. Lalles '{ and 3, keratinocyte R.NAs minus rcverse transcriptase (RT. 
0.9 fLg each); Inlles 2 and 4, keratinocyte R.N As; lalle 5, neutrophil RNA 
minus RT (U.6 fLg) ; Inlle 6, neutrophil RNA; lalle 7. 1 ng full- Icngth FLAP 
cDNA (peR. onl y); olltside Inlles, the DNA ladder. 
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T he allthors ",ollid like to tllnllk T heft'sa COIlIl'''l' jil l' pro"idillg eDNA ./"1' 1"lIl1 all 
S-LO alld FLAP, alld Lisn Mars l",1! nml A lii )' R.os"nk JeI ,. r"ci,.hdp with rite gas 
cltrolllnfographic nllnl)'sis of the kcratillllc),fe lII embra ll e phospholipids. 
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